provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
imageimage
Welcome to the Best Answer series, where experts research your medical questions so you don't have to.
GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, and peer-reviewed scientific journals. However, GoodRx Health's Best Answer series is meant for information purposes only. It is not a substitute for professional medical advice, diagnosis or treatment.

Blood Thinners for Atrial Fibrillation (AFib): Which Is Best?

Amy B. Gragnolati, PharmD, BCPSKatie E. Golden, MD
Updated on February 24, 2025

Direct oral anticoagulants (DOACs) are usually the best blood thinners for preventing stroke in atrial fibrillation (AFib).

One of the main goals of AFib treatment is to prevent stroke. For years, warfarin (Coumadin, Jantoven) was the first-choice blood thinner for this use. But a newer group of medications called DOACs are now considered the best blood thinners for AFib.

Common DOACs include Pradaxa (dabigatran), Xarelto (rivaroxaban), and Eliquis (apixaban). Research has shown that DOACs work better than warfarin at preventing stroke in AFib. And DOACs have an overall lower risk of bleeding.

Still, there are some situations where warfarin is preferred. This includes people with mechanical valves or moderate to severe mitral valve stenosis.

BEST ANSWER

Our answer is in line with current guidelines from the American College of Cardiology and American Heart Association.

THE RESEARCH

Blood thinners for AFib treatment have been extensively studied. The available research supports this answer.

HOW WE GOT HERE

35

Sources consulted

15

Clinical studies reviewed

35

Sources consulted

15

Clinical studies reviewed

Our answer is in line with current guidelines from the American College of Cardiology and American Heart Association.

A doctor and patient discussing different medications.
fizkes/iStock via Getty Images Plus

Atrial fibrillation (AFib) is the most commonly treated heart arrhythmia (irregular heartbeat). One of the main goals of treatment is to prevent stroke — a big risk associated with the condition. Someone with AFib may be up to five times more likely to have a stroke.

A group of medications called anticoagulants are prescribed to prevent the blood clots that lead to stroke in AFib. They’re part of a broader group of medications more commonly referred to as blood thinners.

For many years, warfarin (Coumadin, Jantoven) was the blood thinner of choice in AFib. But a newer group of medications called direct oral anticoagulants (DOACs) are a better option for most people now.

Here, we’ll review the various blood thinners for AFib, and some pros and cons of each.

Are blood thinners recommended if you have AFib?

Yes, most people with AFib take a blood thinner to prevent a type of stroke called an ischemic stroke. An ischemic stroke occurs when blood flow to the brain is blocked, often by a clot. 

In AFib, you’re at higher risk of blood clots because it can affect the way blood flows through the heart. This can cause blood to pool inside the heart chambers, forming a clot. Blood thinners lower the risk of blood clots forming in the body, therefore lowering the risk of stroke.

GoodRx icon
  • Your guide to atrial fibrillation (AFib). Learn all about AFib, including what it is, how it’s diagnosed, and how to treat it. 

  • Blood thinner facts: There are a variety of blood thinner options to choose from. Learn a few facts about the most commonly used ones.

  • Blood thinner interactions. Learn about common blood thinner drug interactions to watch for.

Blood thinners used to treat AFib

Several blood thinners can prevent stroke in AFib. This includes warfarin and several DOACs, namely:

Warfarin was first FDA approved in the 1950s. It’s classified as a vitamin K antagonist, and it works by blocking the activation of vitamin K. The body uses activated vitamin K to make blood clots.

DOACs prevent blood clots in a different way. Think of it like a domino rally. Warfarin focuses on stopping the rally at the very beginning. DOACs focus on removing certain dominoes in the middle.

Warfarin vs. DOACs in AFib: Which is best?

DOACs are now the preferred blood thinner for preventing stroke in AFib. But there are potential downsides compared to warfarin as well.

Advantages of DOACs vs. warfarin

Some advantages of DOACs versus warfarin include:

  • Lower risk of stroke: DOACs work just as well as or better than warfarin at preventing stroke in people with AFib.

  • Lower risk of death: When it comes to overall mortality rate, DOACs are associated with a lower risk of death than warfarin. 

  • Risk of bleeding in the brain: DOACs may have a lower risk of brain bleeds compared to warfarin.

  • Decreased major bleeding risk: Major bleeding is any bleeding that warrants prompt medical treatment. Some research suggests that certain DOACs have a lower risk of major bleeding than warfarin.

  • Less monitoring and fewer checkups: People taking DOACs don’t require as many blood tests as those taking warfarin.

  • Faster onset: DOACs start working faster than warfarin does. It can take warfarin several days to get to the right level in the body.

  • Stopping the medication more easily: DOAC effects don’t last as long as warfarin once you stop taking them. This is a good thing if you’re having surgery and need to stop your blood thinner in advance.

  • Fewer drug and food interactions: People who take warfarin need to pay special attention to their diet and other medications. While DOACs also have possible drug interactions, they aren’t known to interact with foods.

Disadvantages of DOACs vs. warfarin

DOACs have several advantages over warfarin. But there are potential downsides as well. For example:

  • Higher gastrointestinal (GI) bleeding risk: Studies comparing Pradaxa, Xarelto, and Savaysa to warfarin showed that these DOACs are more likely to cause GI bleeding than warfarin. Eliquis has been shown to have a lower risk..

  • Harder to reverse bleeding: If you experience life-threatening bleeding, there are medications that can help quickly reverse the effect of the blood thinner in your body. There are different medications depending on which blood thinner you’re taking, and they all need to be given in a hospital. But some of the reversal medications for DOACs may be more expensive and less readily available.

  • Higher cost: Warfarin and Pradaxa are available as generic medications. Other DOACs are brand-name only. While there are several ways to save on DOACs, warfarin is typically the most affordable blood thinner if you’re paying cash.

Despite some of these downsides, DOACs are the best anticoagulant for most people with AFib.

When is warfarin preferred over DOACs for AFib?

For some people, warfarin is the best blood thinner for AFib treatment. This includes people who have:

Comparing DOACs: Is there a difference between Pradaxa vs. Eliquis vs. Xarelto?

Overall, DOACs are more similar to each other than they are different. They’re considered equally effective at preventing stroke and death in people with AFib. 

A few major differences include:

  • Risk of stomach bleeding: Some research shows that Eliquis has a lower risk of stomach bleeding compared to Pradaxa and Xarelto.

  • Risk of major bleeding: Xarelto has been found to have a higher risk of major bleeding than Pradaxa and Eliquis.

  • Use in kidney disease: Eliquis or Savaysa may be the best DOACs for people with kidney disease.

  • Use in liver disease: Xarelto and Savaysa aren’t recommended in moderate-to-severe liver disease. Warfarin, Pradaxa, or Eliquis may be a better choice.

  • Taking with food: Xarelto is the only DOAC that needs to be taken with meals. And since stomach upset is common with Pradaxa, it may help to take Pradaxa with food as well.

  • Dosage frequency: Savaysa and Xarelto are only taken once a day, while Eliquis and Pradaxa are typically taken twice a day for AFib.

What are the side effects of DOACs and warfarin?

The primary side effect of all blood thinners is abnormal bruising or bleeding. This may include bleeding from the:

  • Gums

  • Nose

  • Stomach, intestine, or rectum

  • Bladder

  • Uterus, or increased menstrual bleeding 

Contact your prescriber immediately if you develop unusual bleeding at any point. They can help you determine how serious it is.

If bleeding seems severe or doesn’t stop, call 911 or seek emergency care instead.

Other side effects

Bleeding aside, specific side effects vary by medication. Your prescriber can walk you through what to expect.

For instance, Eliquis may cause nausea, while Xarelto may cause stomach and back pain. GI side effects like upset stomach, heartburn, and abdominal pain are more common with Pradaxa. GI-related side effects, such as nausea and diarrhea, are possible with warfarin.

Are blood thinners safe for long-term use?

Yes, most people take blood thinners long term for AFib. In many cases, the benefits of taking blood thinners long term — such as lowered risk of stroke, death, and more — outweigh the risk of bleeding. But individual circumstances can change as you age or develop other health conditions.

You and your healthcare team should routinely reassess the benefits and risks of taking a blood thinner.

Make sure to keep up with any office or laboratory appointments your prescriber recommends to monitor your blood thinner medication. This will help your prescriber make sure you’re taking the best dose for you.

Are there alternatives to blood thinners for AFib?

At this time, there’s no alternative to warfarin or DOACs for preventing blood clots in AFib. But some people may qualify for a procedure called a left atrial appendage (LAA) occlusion, which may eliminate the need for blood thinners.

A LAA occlusion procedure involves placing a small, umbrella-like device in a part of the heart called the left atrial appendage. This prevents the formation of blood clots in that area, where most blood clots in AFib start.

However, not everyone is a candidate for an LAA occlusion procedure. As of now, it’s typically only recommended for people who can’t tolerate DOACs, or whose bleeding risk is too high to take a DOAC.

How to save

Warfarin is typically less expensive than DOACs. For example, 30 tablets of 5 mg generic warfarin may cost as low as $4.00 at certain pharmacies with a free GoodRx discount.

The only DOAC that’s currently available as a lower-cost generic medication is Pradaxa. A one-month supply of generic Pradaxa may cost around $65.52 at some pharmacies with a free GoodRx discount.

There are still ways to save on DOACs that are brand-name only:

  • Eliquis: If you have commercial insurance, you could pay as little as $10 per Eliquis prescription with a savings card from the manufacturer. A free trial offer is also available. If you’re uninsured or underinsured, you may be able to receive Eliquis for free through a patient assistance program.

  • Xarelto: If you have commercial insurance, you could pay as little as $10 for your monthly prescription with a savings card from the manufacturer. A patient assistance program is also available.

  • Savaysa: If you have commercial insurance, you could pay as little as $4 for your monthly prescription with a savings card from the manufacturer.

The bottom line

If you have atrial fibrillation (AFib), your cardiologist may recommend taking a blood thinner to help prevent stroke. Blood thinners for AFib include warfarin (Coumadin, Jantoven) and direct oral anticoagulants (DOACs), such as Xarelto (rivaroxaban), Pradaxa (dabigatran), and Eliquis (apixaban).

DOACs are first-choice medications for stroke prevention in Afib. They’re considered more safe and effective when compared to warfarin. However, there are some situations where warfarin may be preferred, such as in people who have a mechanical heart valve or moderate to severe mitral stenosis. Some people may also prefer warfarin because it typically costs less.

When comparing the various DOAC medications, the best option depends on personal factors. For example, Eliquis is known to have the lowest risk of gastrointestinal bleeding. But it has to be taken twice daily, as does Pradaxa. Xarelto and Savaysa are taken once daily in most cases.

why trust our exports reliability shield

Why trust our experts?

Amy B. Gragnolati, PharmD, BCPS
Amy Gragnolati, PharmD, BCPS, is a pharmacy editor for GoodRx. Amy currently holds her pharmacist license in Georgia and California.
Katie E. Golden, MD
Katie E. Golden, MD, is a board-certified emergency medicine physician and a medical editor at GoodRx.

References

American College of Rheumatology. (n.d.). Antiphospholipid syndrome.

American Heart Association. (2024). Problem: Mitral valve stenosis.

View All References (16)

Carnicelli, A. P., et al. (2022). Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: Patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation.

Centers for Disease Control and Prevention. (2024). About atrial fibrillation.

Connolly, S. J., et al. (2009). Dabigatran versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine.

Ganse, E. V., et al. (2020). Comparative safety and effectiveness of oral anticoagulants in nonvalvular atrial fibrillation: The NAXOS study. Stroke.

Giugliano, R. P., et al. (2013). Edoxaban versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine.

Guo, W., et al. (2019). Differences in gastrointestinal safety profiles among novel oral anticoagulants: Evidence from a network meta-analysis. Clinical Epidemiology.

Ingason, A. B., et al. (2023). Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score–weighted study. Blood Advances.

Ntaios, G., et al. (2017). Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: A systematic review and meta-analysis. Stroke.

Patel, M. R., et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. The New England Journal of Medicine.

Pirmohamed, M. (2006). Warfarin: Almost 60 years old and still causing problems. British Journal of Clinical Pharmacology.

Pundi, K., et al. (2021). Blood thinners for atrial fibrillation stroke prevention. Circulation: Arrhythmia and Electrophysiology.

Qiu, J., et al. (2017). Assessing bleeding risk in patients taking anticoagulants. American Family Physician.

Rhee, T., et al. (2022). Efficacy and safety of oral anticoagulants for atrial fibrillation patients with chronic kidney disease: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine.

Sanders, G. D., et al. (2018). Stroke prevention in patients with atrial fibrillation: A systematic review update. Agency for Healthcare Research and Quality.

Souverein, P. C., et al. (2020). Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation. British Journal of Clinical Pharmacology.

StopAfib.org. (2018). Left atrial appendage occlusion devices for stroke prevention.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Boost Heart Health, Not Blood Pressure

Whether you were recently diagnosed with high blood pressure, want to reduce your risk, or want to better understand your treatment options, our free 7-day guide can help.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.